INNOCAN PHARMA Corp
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INNPF research report →
Companyinnocanpharma.com
InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Poland, France, and internationally. The company engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes. Its product includes CBD eye serum, CBD face oil, CBD face cream, CBD facial serum, CBD sleeping mask, CBD recovery lotion, and the Relief & Go spray.
- CEO
- Iris Bincovich
- IPO
- 2020
- Employees
- 11
- HQ
- Calgary, AB, CA
Price Chart
Valuation
- Market Cap
- $19.79M
- P/E
- -14.48
- P/S
- 0.61
- P/B
- 2.91
- EV/EBITDA
- 81.55
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 89.93%
- Op Margin
- -4.72%
- Net Margin
- -4.22%
- ROE
- -24.52%
- ROIC
- 54.92%
Growth & Income
- Revenue
- $26.61M · -9.60%
- Net Income
- $-1,124,000 · 38.71%
- EPS
- $-0.25 · 40.48%
- Op Income
- $-1,255,000
- FCF YoY
- 130.05%
Performance & Tape
- 52W High
- $14.26
- 52W Low
- $4.34
- 50D MA
- $13.01
- 200D MA
- $13.01
- Beta
- -0.25
- Avg Volume
- 325
Get TickerSpark's AI analysis on INNPF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our INNPF Coverage
We haven't published any research on INNPF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate INNPF Report →